Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los

This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this e

This is a RCT that aims to assess the effectiveness of vaccine chatbots in increasing COVID-19 vaccine confidence and uptake in populations that have been hesitant to receive the COVID-19 vaccine in Thailand, Singapore, and Hong Kong.chatbot,vaccine

Objective: Implementing national-level vaccination programs involves long-term investment, which can be a significant financial burden, particularly in resource-limited settings. Although many studies have assessed the economic impacts of providing vaccinations, evidence on the positive and negative

Abstract Background Health surveillance and survey data are helpful in evidence-informed policy decisions. This study is part of an evaluation of the National Health Examination Survey (NHES) programme in Thailand. This paper focuses on the obstacles in the translation of survey information into

How do decision-makers in Thailand decide whether a new or improved vaccine should be added to the Expanded Program on Immunization (EPI)?What is the vaccine prioritization and selection processes in Thailand?How can the product preferences of low and middle-income countries (LMICS) be better commun

Abstract Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa

It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo

Using health technology assessment for informing coverage decisions in Thailand. Mohara, A., Youngkong, S., Velasco, R. P., Werayingyong, P., Pachanee, K., Prakongsai, P., … & Teerawattananon, Y. (2012). Using health technology assessment for informing coverage decisions in Thailand. Full

HITAP team facilitated a two and a half day workshop in Kathmandu, Nepal on March 30 – April 1, 2015 at the request of the Nepalese Ministry of Health and Population (MoHP). The goal of the workshop was to explore the potential application of health and technology assessment (HTA) to evaluate and in